Inflammatory markers in relation to cachexia in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003
Inflammatory markers in COPD patients with and without cachexia Source: Annual Congress 2012 - COPD comorbidities II Year: 2012
Lipid profiles with COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 442s Year: 2001
Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019
Evolution of cellular inflammatory pattern in induced sputum in patients with mild-moderate asthma for five years Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Inflammatory markers of atherogenesis in patients with uncontrolled severe asthma Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017
COPD, an inflammatory systemic disease. Inflammatory parameters in a group of COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014
Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
Inflammatory phenotypes of COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015
Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011
Inflammatory markers (IL-6, suPAR) and arterial stiffness parameters in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008
Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009
Systemic inflammatory response during one year follow-up in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 13s Year: 2004
Metabolic and inflammatory profile in patients with COPD and physical activity. Source: Virtual Congress 2021 – Pulmonary rehabilitation in asthma and COPD Year: 2021
Identifying systemic inflammatory markers in the Melbourne COPD exacerbation cohort Source: Eur Respir J 2005; 26: Suppl. 49, 51s Year: 2005
Inflammatory markers and HDAC activity in induced sputum of smokers and COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 586s Year: 2007
Metabolic syndrome in patients with COPD and their association with systemic inflammation Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015
Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015